This content will become publicly available on December 26, 2020
Niacin for Parkinson's disease
- Authors:
-
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Neuroscience Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Undergraduate Health Professionals Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Physical Therapy Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Oral Biology and Diagnostic Sciences Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Neurology Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Interdisciplinary Health Sciences Augusta University Augusta Georgia USA
- Charlie Norwood VA Medical Center Augusta Georgia USA, Department of Neuroscience Augusta University Augusta Georgia USA, Department of Physical Therapy Augusta University Augusta Georgia USA, Department of Neurology Augusta University Augusta Georgia USA
- Publication Date:
- Sponsoring Org.:
- USDOE Office of Electricity Delivery and Energy Reliability (OE), Power Systems Engineering Research and Development (R&D) (OE-10)
- OSTI Identifier:
- 1580552
- Resource Type:
- Publisher's Accepted Manuscript
- Journal Name:
- Clinical and Experimental Neuroimmunology
- Additional Journal Information:
- Journal Name: Clinical and Experimental Neuroimmunology; Journal ID: ISSN 1759-1961
- Publisher:
- Wiley-Blackwell
- Country of Publication:
- Country unknown/Code not available
- Language:
- English
Citation Formats
Seamon, Marissa, Purohit, Sharad, Giri, Banabihari, Baban, Babak, Morgan, John, Chong, Raymond, and Wakade, Chandramohan. Niacin for Parkinson's disease. Country unknown/Code not available: N. p., 2019.
Web. doi:10.1111/cen3.12553.
Seamon, Marissa, Purohit, Sharad, Giri, Banabihari, Baban, Babak, Morgan, John, Chong, Raymond, & Wakade, Chandramohan. Niacin for Parkinson's disease. Country unknown/Code not available. doi:10.1111/cen3.12553.
Seamon, Marissa, Purohit, Sharad, Giri, Banabihari, Baban, Babak, Morgan, John, Chong, Raymond, and Wakade, Chandramohan. Fri .
"Niacin for Parkinson's disease". Country unknown/Code not available. doi:10.1111/cen3.12553.
@article{osti_1580552,
title = {Niacin for Parkinson's disease},
author = {Seamon, Marissa and Purohit, Sharad and Giri, Banabihari and Baban, Babak and Morgan, John and Chong, Raymond and Wakade, Chandramohan},
abstractNote = {},
doi = {10.1111/cen3.12553},
journal = {Clinical and Experimental Neuroimmunology},
number = ,
volume = ,
place = {Country unknown/Code not available},
year = {2019},
month = {12}
}
Free Publicly Available Full Text
This content will become publicly available on December 26, 2020
Publisher's Version of Record
DOI: 10.1111/cen3.12553
Other availability
Search WorldCat to find libraries that may hold this journal
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Nicotinamide Treatment Provides Acute Neuroprotection and GFAP Regulation following Fluid Percussion Injury
journal, February 2008
- Holland, Michael A.; Tan, Arlene A.; Smith, Douglas C.
- Journal of Neurotrauma, Vol. 25, Issue 2
A novel treatment target for Parkinson's disease
journal, December 2014
- Wakade, Chandramohan; Chong, Raymond
- Journal of the Neurological Sciences, Vol. 347, Issue 1-2
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
journal, January 2014
- Singh, Nagendra; Gurav, Ashish; Sivaprakasam, Sathish
- Immunity, Vol. 40, Issue 1
Zolpidem improves akinesia, dystonia and dyskinesia in advanced Parkinson’s disease
journal, August 2008
- Chen, Yen-Yu; Sy, Hiu-Ngar; Wu, Shey-Lin
- Journal of Clinical Neuroscience, Vol. 15, Issue 8
Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease: Preladenant Long-Term Safety and Efficacy
journal, April 2013
- Factor, Stewart A.; Wolski, Kenneth; Togasaki, Daniel M.
- Movement Disorders, Vol. 28, Issue 6
Niacin modulates macrophage polarization in Parkinson's disease
journal, July 2018
- Wakade, Chandramohan; Giri, Banabihari; Malik, Aneeq
- Journal of Neuroimmunology, Vol. 320
Anti-Inflammatory Effects of Nicotinic Acid in Human Monocytes Are Mediated by GPR109A Dependent Mechanisms
journal, March 2012
- Digby, Janet E.; Martinez, Fernando; Jefferson, Andrew
- Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 32, Issue 3
The Niacin/Butyrate Receptor GPR109A Suppresses Mammary Tumorigenesis by Inhibiting Cell Survival
journal, December 2013
- Elangovan, S.; Pathania, R.; Ramachandran, S.
- Cancer Research, Vol. 74, Issue 4
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
journal, March 2011
- Lukasova, Martina; Malaval, Camille; Gille, Andreas
- Journal of Clinical Investigation, Vol. 121, Issue 3
Istradefylline as monotherapy for Parkinson disease: Results of the 6002-US-051 trial
journal, January 2010
- Fernandez, H. H.; Greeley, D. R.; Zweig, R. M.
- Parkinsonism & Related Disorders, Vol. 16, Issue 1
Nilotinib Effects in Parkinson’s disease and Dementia with Lewy bodies
journal, August 2016
- Pagan, Fernando; Hebron, Michaeline; Valadez, Ellen H.
- Journal of Parkinson's Disease, Vol. 6, Issue 3
Microglial/Macrophage Polarization Dynamics following Traumatic Brain Injury
journal, October 2016
- Kumar, Alok; Alvarez-Croda, Dulce-Mariely; Stoica, Bogdan A.
- Journal of Neurotrauma, Vol. 33, Issue 19
Zolpidem in Parkinson's disease
journal, April 1997
- Daniele, Antonio; Albanese, Alberto; Gainotti, Guido
- The Lancet, Vol. 349, Issue 9060
Niacin improved rigidity and bradykinesia in a Parkinson's disease patient but also caused unacceptable nightmares and skin rash—A case report
journal, October 2005
- Alisky, Joseph Martin
- Nutritional Neuroscience, Vol. 8, Issue 5-6
Zonisamide has beneficial effects on Parkinson's disease patients
journal, December 2001
- Murata, Miho; Horiuchi, Emiko; Kanazawa, Ichiro
- Neuroscience Research, Vol. 41, Issue 4
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinson's disease models
journal, May 2013
- Hebron, M. L.; Lonskaya, I.; Moussa, C. E. - H.
- Human Molecular Genetics, Vol. 22, Issue 16
Oral Exposure to Paraquat Triggers Earlier Expression of Phosphorylated α-Synuclein in the Enteric Nervous System of A53T Mutant Human α-Synuclein Transgenic Mice
journal, October 2017
- Naudet, Nicolas; Antier, Emilie; Gaillard, Damien
- Journal of Neuropathology & Experimental Neurology, Vol. 76, Issue 12
Upregulation of GPR109A in Parkinson’s Disease
journal, October 2014
- Wakade, Chandramohan; Chong, Raymond; Bradley, Eric
- PLoS ONE, Vol. 9, Issue 10
Oxidative stress in Parkinson's disease
journal, January 2003
- Jenner, Peter
- Annals of Neurology, Vol. 53, Issue S3
The Effect of Coenzyme Q10 Therapy in Parkinson Disease Could Be Symptomatic
journal, August 2003
- Horstink, Martin W. I. M.
- Archives of Neurology, Vol. 60, Issue 8
GPR109A and Vascular Inflammation
journal, March 2013
- Chai, Joshua T.; Digby, Janet E.; Choudhury, Robin P.
- Current Atherosclerosis Reports, Vol. 15, Issue 5
Lewy body diseases and multiple system atrophy as α-synucleinopathies
journal, November 1998
- Goedert, M.; Spillantini, M. G.
- Molecular Psychiatry, Vol. 3, Issue 6
Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages
journal, October 2014
- Feingold, Kenneth R.; Moser, Arthur; Shigenaga, Judy K.
- Journal of Lipid Research, Vol. 55, Issue 12
Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms: preliminary results
journal, September 2012
- Hasan, David; Chalouhi, Nohra; Jabbour, Pascal
- Journal of Neuroinflammation, Vol. 9, Issue 1
Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness
journal, July 2018
- Seth, Ratanesh Kumar; Kimono, Diana; Alhasson, Firas
- Toxicology and Applied Pharmacology, Vol. 350
Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress
journal, September 2017
- Coles, Lisa D.; Tuite, Paul J.; Öz, Gülin
- The Journal of Clinical Pharmacology, Vol. 58, Issue 2
-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
journal, May 1998
- Spillantini, M. G.; Crowther, R. A.; Jakes, R.
- Proceedings of the National Academy of Sciences, Vol. 95, Issue 11
Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects
journal, June 2015
- Wakade, Chandramohan; Chong, Raymond; Bradley, Eric
- Clinical Case Reports, Vol. 3, Issue 7
Interaction Among Mitochondria, Mitogen-Activated Protein Kinases, and Nuclear Factor-κB in Cellular Models of Parkinson's Disease
journal, April 2000
- Cassarino, David S.; Halvorsen, Erik M.; Swerdlow, Russell H.
- Journal of Neurochemistry, Vol. 74, Issue 4
Adenosine A 2A receptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
journal, March 2008
- LeWitt, Peter A.; Guttman, M.; Tetrud, James W.
- Annals of Neurology, Vol. 63, Issue 3
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
journal, May 2009
- Chaudhuri, K. Ray; Schapira, Anthony HV
- The Lancet Neurology, Vol. 8, Issue 5
PUMA-G, an IFN-γ-inducible gene in macrophages is a novel member of the seven transmembrane spanning receptor superfamily
journal, December 2001
- Schaub, Annette; Fütterer, Agnes; Pfeffer, Klaus
- European Journal of Immunology, Vol. 31, Issue 12
Soluble, Prefibrillar α-Synuclein Oligomers Promote Complex I-dependent, Ca 2+ -induced Mitochondrial Dysfunction
journal, June 2014
- Luth, Eric S.; Stavrovskaya, Irina G.; Bartels, Tim
- Journal of Biological Chemistry, Vol. 289, Issue 31
Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system
journal, June 2012
- Hernández-Romero, Mª Carmen; Delgado-Cortés, Mª José; Sarmiento, Manuel
- NeuroToxicology, Vol. 33, Issue 3
Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts
journal, October 1997
- Ma, Shuang Yong; Röyttä, Matias; Rinne, Juha O.
- Journal of the Neurological Sciences, Vol. 151, Issue 1
Decreased Activity of 3-Hydroxybutyrate Dehydrogenase in Diabetic Liver Mitochondria
journal, July 1971
- Roldan, A. G.; Del Castillo, E. J.; Boveris, A.
- Experimental Biology and Medicine, Vol. 137, Issue 3
Impairment of glutamate uptake and absence of alterations in the energy-transducing ability of old rat brain mitochondria
journal, March 1985
- Vitorica, Javier; Clark, Arthur; Machado, Alberto
- Mechanisms of Ageing and Development, Vol. 29, Issue 3
Treatment of End-of-Dose Wearing-Off in Parkinson’s Disease: Stalevo<sup>®</sup> (Levodopa/Carbidopa/Entacapone) and Levodopa/DDCI Given in Combination with Comtess<sup>®</sup>/Comtan<sup>®</sup> (Entacapone) Provide Equivalent Improvements in Symptom Control Superior to That of Traditional Levodopa/DDCI Treatment
journal, January 2005
- Brooks, D. J.; Agid, Y.; Eggert, K.
- European Neurology, Vol. 53, Issue 4
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
journal, March 2019
- Pagan, Fernando L.; Hebron, Michaeline L.; Wilmarth, Barbara
- Pharmacology Research & Perspectives, Vol. 7, Issue 2
Oral butyrate for mildly to moderately active Crohn's disease
journal, November 2005
- Sabatino, A. Di; Morera, R.; Ciccocioppo, R.
- Alimentary Pharmacology and Therapeutics, Vol. 22, Issue 9
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
journal, December 2005
- Benyó, Zoltán; Gille, Andreas; Kero, Jukka
- Journal of Clinical Investigation, Vol. 115, Issue 12
Niaspan reduces high-mobility group box 1/receptor for advanced glycation endproducts after stroke in type-1 diabetic rats
journal, September 2011
- Ye, X.; Chopp, M.; Liu, X.
- Neuroscience, Vol. 190
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
journal, March 2005
- Rascol, O.; Brooks, Dj; Melamed, E.
- The Lancet, Vol. 365, Issue 9463
Levodopa-induced dyskinesias
journal, January 2007
- Fabbrini, Giovanni; Brotchie, Jonathan M.; Grandas, Francisco
- Movement Disorders, Vol. 22, Issue 10
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson’s disease
journal, May 2017
- Martin-Bastida, Antonio; Ward, Roberta J.; Newbould, Rexford
- Scientific Reports, Vol. 7, Issue 1
Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
journal, January 2004
- Stern, Matthew B.; Marek, Kenneth L.; Friedman, Joseph
- Movement Disorders, Vol. 19, Issue 8
Phase IIb Study of Intranasal Glutathione in Parkinson’s Disease
journal, May 2017
- Mischley, Laurie K.; Lau, Richard C.; Shankland, Eric G.
- Journal of Parkinson's Disease, Vol. 7, Issue 2
A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinson's disease: PHASE I/IIA (IN)GSH IN PD
journal, July 2015
- Mischley, Laurie K.; Leverenz, James B.; Lau, Richard C.
- Movement Disorders, Vol. 30, Issue 12
A Population-Based Investigation of Parkinson's Disease With and Without Dementia: Relationship to Age and Gender
journal, May 1992
- Mayeux, Richard
- Archives of Neurology, Vol. 49, Issue 5
Treatment of Parkinson's Syndrome with L Dihydroxyphenylalanine (Levodopa)
journal, January 1970
- Mcdowell, Fletcher
- Annals of Internal Medicine, Vol. 72, Issue 1
Anti-inflammatory drugs and risk of Parkinson disease: A meta-analysis
journal, March 2010
- Gagne, J. J.; Power, M. C.
- Neurology, Vol. 74, Issue 12
Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease
journal, July 2014
- Aviles-Olmos, Iciar; Dickson, John; Kefalopoulou, Zinovia
- Journal of Parkinson's Disease, Vol. 4, Issue 3
GPR109A as an Anti-Inflammatory Receptor in Retinal Pigment Epithelial Cells and Its Relevance to Diabetic Retinopathy
journal, April 2012
- Gambhir, Deeksha; Ananth, Sudha; Veeranan-Karmegam, Rajalakshmi
- Investigative Opthalmology & Visual Science, Vol. 53, Issue 4
Utilization of tryptophan, nicotinamide and nicotinic acid as precursors for nicotinamide nucleotide synthesis in isolated rat liver cells
journal, March 1988
- Bender, David A.; Olufunwa, Ronald
- British Journal of Nutrition, Vol. 59, Issue 2
N-acetylcysteine Boosts Brain and Blood Glutathione in Gaucher and Parkinson Diseases
journal, January 2013
- Holmay, Mary J.; Terpstra, Melissa; Coles, Lisa D.
- Clinical Neuropharmacology, Vol. 36, Issue 4
Mitochondrial Complex I Deficiency in Parkinson's Disease
journal, March 1990
- Schapira, A. H. V.; Cooper, J. M.; Dexter, D.
- Journal of Neurochemistry, Vol. 54, Issue 3
Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD
journal, August 2003
- Hauser, Robert A.; Hubble, Jean P.; Truong, Daniel D.
- Neurology, Vol. 61, Issue 3
Niacin Depletion in Parkinsonian Patients Treated with L-dopa, Benserazide and Carbidopa
journal, January 1979
- Bender, D. A.; Earl, C. J.; Lees, A. J.
- Clinical Science, Vol. 56, Issue 1
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
journal, May 1996
- Hunot, S.; Boissière, F.; Faucheux, B.
- Neuroscience, Vol. 72, Issue 2
Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia
journal, November 2012
- Hu, Xiaoming; Li, Peiying; Guo, Yanling
- Stroke, Vol. 43, Issue 11
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
journal, July 2006
- Offermanns, S.
- Trends in Pharmacological Sciences, Vol. 27, Issue 7
Ageing and Parkinson'S Disease: Substantia Nigra Regional Selectivity
journal, January 1991
- Fearnley, Julian M.; Lees, Andrew J.
- Brain, Vol. 114, Issue 5
Search for neurotoxins structurally related to 1-methyl-4-phenylpyridine (MPP+) in the pathogenesis of Parkinson's disease
journal, March 1992
- Ikeda, Hiroya; Markey, Carol J.; Markey, Sanford P.
- Brain Research, Vol. 575, Issue 2
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
journal, October 2017
- Athauda, Dilan; Maclagan, Kate; Skene, Simon S.
- The Lancet, Vol. 390, Issue 10103
GPR109A Is a G-protein-Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon
journal, March 2009
- Thangaraju, M.; Cresci, G. A.; Liu, K.
- Cancer Research, Vol. 69, Issue 7
Intravenous flumazenil for Parkinson's disease: A single dose, double blind, placebo controlled, cross-over trial
journal, January 2006
- Ondo, William G.; Silay, Yavuz S.
- Movement Disorders, Vol. 21, Issue 10
A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics
journal, May 2016
- Yoritaka, Asako; Abe, Takashi; Ohtsuka, Chigumi
- BMC Neurology, Vol. 16, Issue 1
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD): Serum Immune Markers and PD Progression
journal, March 2016
- Williams-Gray, Caroline H.; Wijeyekoon, Ruwani; Yarnall, Alison J.
- Movement Disorders, Vol. 31, Issue 7
Mitochondrial function in Parkinson's disease
journal, January 1992
- Schapira, Anthony H. V.; Mann, Vincent M.; Cooper, J. Mark
- Annals of Neurology, Vol. 32, Issue S1
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
journal, December 2000
- Betarbet, Ranjita; Sherer, Todd B.; MacKenzie, Gillian
- Nature Neuroscience, Vol. 3, Issue 12
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
journal, January 2003
- Wise, Alan; Foord, Steven M.; Fraser, Neil J.
- Journal of Biological Chemistry, Vol. 278, Issue 11
Effects of rotenone and pyridaben on complex I electron transfer and on mitochondrial nitric oxide synthase functional activity
journal, October 2010
- Navarro, Ana; Bández, Manuel J.; Gómez, Carmen
- Journal of Bioenergetics and Biomembranes, Vol. 42, Issue 5
Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
journal, February 2019
- Silveira, C. R. A.; MacKinley, J.; Coleman, K.
- BMC Neurology, Vol. 19, Issue 1
Anti-inflammatory effects of nicotinic acid in adipocytes demonstrated by suppression of fractalkine, RANTES, and MCP-1 and upregulation of adiponectin
journal, March 2010
- Digby, Janet E.; McNeill, Eileen; Dyar, Oliver J.
- Atherosclerosis, Vol. 209, Issue 1
Niacin Treatment of Stroke Increases Synaptic Plasticity and Axon Growth in Rats
journal, September 2010
- Cui, Xu; Chopp, Michael; Zacharek, Alex
- Stroke, Vol. 41, Issue 9
A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes
journal, May 2011
- Rascol, Olivier; Fitzer-Attas, Cheryl J.; Hauser, Robert
- The Lancet Neurology, Vol. 10, Issue 5
Zonisamide: A new drug for Parkinson's disease
journal, January 2010
- Murata, M.
- Drugs of Today, Vol. 46, Issue 4
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
journal, February 2006
- Gerhard, Alexander; Pavese, Nicola; Hotton, Gary
- Neurobiology of Disease, Vol. 21, Issue 2
In vivo demonstration that -synuclein oligomers are toxic
journal, February 2011
- Winner, B.; Jappelli, R.; Maji, S. K.
- Proceedings of the National Academy of Sciences, Vol. 108, Issue 10
Effects of Niacin Restriction on Sirtuin and PARP Responses to Photodamage in Human Skin
journal, July 2012
- Benavente, Claudia A.; Schnell, Stephanie A.; Jacobson, Elaine L.
- PLoS ONE, Vol. 7, Issue 7
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
journal, May 2017
- Stocchi, Fabrizio; Rascol, Olivier; Hauser, Robert A.
- Neurology, Vol. 88, Issue 23
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
journal, March 2011
- Hauser, Robert A.; Cantillon, Marc; Pourcher, Emmanuelle
- The Lancet Neurology, Vol. 10, Issue 3
α-Synuclein Activates Microglia by Inducing the Expressions of Matrix Metalloproteinases and the Subsequent Activation of Protease-Activated Receptor-1
journal, May 2010
- Lee, Eun-Jung; Woo, Moon-Sook; Moon, Pyong-Gon
- The Journal of Immunology, Vol. 185, Issue 1
Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson’s disease
journal, July 2015
- Jucaite, Aurelija; Svenningsson, Per; Rinne, Juha O.
- Brain, Vol. 138, Issue 9
Microglia and neurodegeneration: The role of systemic inflammation
journal, June 2012
- Cunningham, Colm
- Glia, Vol. 61, Issue 1
Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates
journal, May 2011
- Collier, Timothy J.; Kanaan, Nicholas M.; Kordower, Jeffrey H.
- Nature Reviews Neuroscience, Vol. 12, Issue 6
Randomized, double-blind, multicenter trial of hydrogen water for Parkinson's disease: LETTERS: NEW OBSERVATIONS
journal, September 2018
- Yoritaka, Asako; Ohtsuka, Chigumi; Maeda, Tetsuya
- Movement Disorders, Vol. 33, Issue 9
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
journal, April 2013
- Taylor, Juliet M.; Main, Bevan S.; Crack, Peter J.
- Neurochemistry International, Vol. 62, Issue 5
The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages
journal, May 2014
- Rahman, Mahbubur; Muhammad, Sajjad; Khan, Mahtab A.
- Nature Communications, Vol. 5, Issue 1
Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
journal, August 1997
- Shults, Clifford W.; Haas, Richard H.; Passov, David
- Annals of Neurology, Vol. 42, Issue 2
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson’s Disease
journal, August 2019
- Kim, Sangjune; Kwon, Seung-Hwan; Kam, Tae-In
- Neuron, Vol. 103, Issue 4
MDS clinical diagnostic criteria for Parkinson's disease: MDS-PD Clinical Diagnostic Criteria
journal, October 2015
- Postuma, Ronald B.; Berg, Daniela; Stern, Matthew
- Movement Disorders, Vol. 30, Issue 12
A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease: Randomized Trial of P2B001 in Early PD
journal, April 2017
- Olanow, C. Warren; Kieburtz, Karl; Leinonen, Mika
- Movement Disorders, Vol. 32, Issue 5
Prevalence of Parkinson’s disease across North America
journal, July 2018
- Marras, C.; Beck, J. C.; Bower, J. H.
- npj Parkinson's Disease, Vol. 4, Issue 1
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
journal, September 2014
- Chagas, Marcos Hortes N.; Zuardi, Antonio W.; Tumas, Vitor
- Journal of Psychopharmacology, Vol. 28, Issue 11
Randomized Delayed-Start Trial of Levodopa in Parkinson’s Disease
journal, January 2019
- Verschuur, Constant V. M.; Suwijn, Sven R.; Boel, Judith A.
- New England Journal of Medicine, Vol. 380, Issue 4
Oxidative damage to macromolecules in human Parkinson disease and the rotenone model
journal, September 2013
- Sanders, Laurie H.; Timothy Greenamyre, J.
- Free Radical Biology and Medicine, Vol. 62
Characterization of Determinants of Ligand Binding to the Nicotinic Acid Receptor GPR109A (HM74A/PUMA-G)
journal, August 2005
- Tunaru, Sorin; Lättig, Jens; Kero, Jukka
- Molecular Pharmacology, Vol. 68, Issue 5
Zonisamide in patients with essential tremor and Parkinson's disease
journal, October 2007
- Bermejo, Pedro Emilio
- Movement Disorders, Vol. 22, Issue 14
Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
journal, January 2010
- Pan-Montojo, Francisco; Anichtchik, Oleg; Dening, Yanina
- PLoS ONE, Vol. 5, Issue 1
The genetics of Parkinson disease
journal, March 2018
- Deng, Hao; Wang, Peng; Jankovic, Joseph
- Ageing Research Reviews, Vol. 42
Evidence of Inflammatory System Involvement in Parkinson’s Disease
journal, January 2014
- Chao, Yinxia; Wong, Siew Cheng; Tan, Eng King
- BioMed Research International, Vol. 2014
α-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration
journal, November 2017
- Harms, Ashley S.; Delic, Vedad; Thome, Aaron D.
- Acta Neuropathologica Communications, Vol. 5, Issue 1
Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet®), sustained-release carbidopa-levodopa (Sinemet® CR), and carbidopa-levodopa-entacapone (: The Journal of Clinical Pharmacology
journal, May 2015
- Hsu, Ann; Yao, Hsuan-Ming; Gupta, Suneel
- The Journal of Clinical Pharmacology, Vol. 55, Issue 9
Variation in Chronic Nicotinamide Treatment after Traumatic Brain Injury Can Alter Components of Functional Recovery Independent of Histological Damage
journal, January 2008
- Hoane, Michael R.; Pierce, Jeremy L.; Kaufman, Nicholas A.
- Oxidative Medicine and Cellular Longevity, Vol. 1, Issue 1
Niaspan treatment induces neuroprotection after stroke
journal, October 2010
- Shehadah, Amjad; Chen, Jieli; Zacharek, Alex
- Neurobiology of Disease, Vol. 40, Issue 1
Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease: Glutathione in Parkinson's Disease
journal, February 2009
- Hauser, Robert A.; Lyons, Kelly E.; McClain, Terry
- Movement Disorders, Vol. 24, Issue 7
Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
journal, October 2012
- Lindqvist, Daniel; Kaufman, Eli; Brundin, Lena
- PLoS ONE, Vol. 7, Issue 10
Seeding induced by α-synuclein oligomers provides evidence for spreading of α-synuclein pathology
journal, October 2009
- Danzer, Karin M.; Krebs, Simon K.; Wolff, Michael
- Journal of Neurochemistry, Vol. 111, Issue 1
Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord
journal, October 2009
- Kigerl, K. A.; Gensel, J. C.; Ankeny, D. P.
- Journal of Neuroscience, Vol. 29, Issue 43
Flumazenil, a GABA antagonist, may improve features of Parkinson's disease
journal, February 2003
- Ondo, William G.; Hunter, Christine
- Movement Disorders, Vol. 18, Issue 6
Effect of Niacin on Inflammation and Angiogenesis in a Murine Model of Ulcerative Colitis
journal, August 2017
- Salem, Hesham Aly; Wadie, Walaa
- Scientific Reports, Vol. 7, Issue 1
An open-label evaluation of the tolerability and safety of Stalevo� (carbidopa, levodopa and entacapone) in Parkinson?s disease patients experiencing wearing-off
journal, October 2004
- Koller, W.; Guarnieri, M.; Hubble, J.
- Journal of Neural Transmission, Vol. 112, Issue 2
Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience
journal, April 2017
- Nishijima, Haruo; Ueno, Tatsuya; Kon, Tomoya
- Journal of the Neurological Sciences, Vol. 375